Načítá se...
Off-label use of anti-IL-1 drugs in rheumatic diseases
Interleukin-1 (IL-1) plays a key role in the pathogenesis of different rheumatic diseases. There are now several agents available on the market capable of blocking IL-1. The proven effectiveness and excellent safety of these drugs makes them a possible therapeutic option in the treatment of IL-1 dri...
Uloženo v:
| Vydáno v: | Int J Immunopathol Pharmacol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8056561/ https://ncbi.nlm.nih.gov/pubmed/33855881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/20587384211006584 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|